News

Net Profit up 17.6% At ₹274 Cr Vs ₹233 Cr (YoY)

Revenue up 20% At ₹1,375 Cr Vs ₹1,146 Cr (YoY)

EBITDA up 19.2% At ₹382.5 Cr Vs ₹321 Cr (YoY)

Margin At 27.8% Vs 28% (YoY)

CG Power Arm Wins ₹433 crore KAVACH Order From Chittaranjan Locomotive Works

Market Records Weekly Gains Despite A Fall On Friday, Sensex & Nifty Gain Over 1% Each

Broader Markets Outperform, Nifty Bank & Midcap Index Rise Over 2% Each

Defence, Capital Market, Realty & Metal Stocks Gain The Most, Rise Up To 9%

BEL, ONGC, Axis Bank, Adani Ports, Adani Ent Are Top Nifty Gainers

Asian Paints, Maruti Suzuki, Kotak Mahindra Bank, Max Health, M&M Are Top Nifty Losers

Oil India, MRPL, Voda Idea, Mazagon Dock, Cochin Shipyard Are Top Midcap Gainers

Hind Zinc, Newgen Software, KPIT Tech, Bharti Hexacom, Poonawalla Fin Are Top Midcap Losers

Market Snaps The 3-day Winning Streak, All Major Indices Close In The Red

Nifty Closes Below 25,350, Hindalco, Tata Steel, Coal India, ONGC, ICICI Bk Are Top Losers

Market Breadth Is In Favour Of Advances Despite All Major Indices Being Lower

Metal Index Snaps 3-day Winning Streak, Hind Copper, Hind Zinc & Other Metal Stocks Fall Up To 12%

Sensex Falls 297 Points To 82,270, Nifty 98 Points To 25,321

Nifty Bank Falls 347 Points To 59,610, Midcap Index 109 Points To 58,432

Swiggy Falls Over 5% As Net Loss Widens To `1,065 Cr, CLSA Downgrade

Indoco Remedies Gains 2% Post USFDA Approval For Lacosamide Oral Solution

Nestle Emerges As Top Nifty Gainer, Rises 3% After Co Posts Q3 Results Above Estimates

Ambuja Cements Falls 5% On Weak Q3 Results

Brigade Ent Rises Over 2% While MOIL Falls 4% Post Q3 Results

South Indian Bank Falls Over 15% As CEO Does Not Seek Reappointment

Voda Idea Emerges As The Top Midcap Gainer, Rises Over 11% In Today’s Trade

NSE Advance-Decline Ratio At 3:2

Net Profit up 9% At ₹86.1 Cr Vs ₹79 Cr (YoY)

Revenue up 1% At ₹1,168 Cr Vs ₹1,155 Cr (YoY)

EBITDA up 32% At ₹201.5 Cr Vs ₹152.7 Cr (YoY)

Margin At 17.2% Vs 13.2% (YoY)

Rupee Ends At 91.98/$ Against Thursday’s Close Of 91.96/$

Gurmeet Chadha, Managing Partner & CIO, Complete Circle

“Strides Pharma is not in our portfolio. But, numbers look good. In pharma sector we have Laurus Labs, Divi’s Lab, Neuland Lab in the portfolio. So we are more positioned on the CDMO side. There’s been some profit taking from the peak and some consolidation. But we believe this is a very long-term opportunity. I think the pharma outsourcing industry, especially novel custom synthesis will see huge opportunities picking up. And I think after this UFT, also Pharma is one of the underappreciated beneficiaries in the medium term. So we are more positioned there and happy to look at, you know, some of the generic names that have seen very healthy correction in the likes of, let’s say, Mankind Pharma post the acquisition they have done, Cipla, etc. So we are overweight pharma.”

MCX Silver plunged 15%, falling ₹59,983 to ₹3,39,910 per kg.

Net Profit At ₹1,595 Cr Vs CNBC-TV18 Poll Of ₹1,555 Cr

Revenue At ₹4,731 Cr Vs CNBC-TV18 Poll Of ₹4,499 Cr

EBITDA At ₹2,182.3 Cr Vs CNBC-TV18 Poll Of ₹2,149 Cr

Margin At 46.1% Vs CNBC-TV18 Poll Of 47.8%

Net Profit up 1.8% At ₹1,595 Cr Vs ₹1,566 Cr (YoY)

Revenue up 1.5% At ₹4,731 Cr Vs ₹4,662 Cr (YoY)

EBITDA down 1.8% At ₹2,182.3 Cr Vs ₹2,222.8 Cr (YoY)

Margin At 46.1% Vs 47.7% (YoY)

Net Profit up 20% At ₹10.2 Cr Vs ₹8.5 Cr (YoY)

Revenue up 15.8% At ₹416.3 Cr Vs ₹359.4 Cr (YoY)

EBITDA At ₹41 Cr Vs ₹17.3 Cr (YoY)

Margin At 9.8% Vs 4.8% (YoY)

Market reacts after Welspun Corp reports a 32.8% drop in Net Profit.

The stock slumped over 4.5% following week Q3 performance.

Nestle India shares surged following good Q3 results as the company performed much better than market expectations.

Shares of the company declined 8.64% reaching the intraday low of ₹588.80 following the Q3 result announcement.

Net Profit down 39.7% At ₹10.5 Cr Vs ₹17.4 Cr (YoY)

Revenue up 7.6% At ₹385 Cr Vs ₹357.7 Cr (YoY)

EBITDA down 11% At ₹27.5 Cr Vs ₹31 Cr (YoY)

Margin At 7.1% Vs 8.6% (YoY)

The shares of MOIL recovered from the lows of the day to rise close to 1% after the company announced its results.

The shares of Strides Pharma surged by over 7% after the company announced its results for the third quarter.

On Friday, January 30, shares of Indoco Remedies Limited increased by more than 8.5% after the company announced that it had received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lacosamide Oral Solution USP, 10 mg/mL, adding to its portfolio of US generics.

==========================================

==========================================

SpiceJet | Enters Imphal, Launches Daily Flights from Kolkata, Guwahati and Mumbai

The shares of Rattan India are up over 2% after the company announced its results.

The shares of Arvind have risen by over 7% after the company announced its results, adding to the 2% in the past month of trade.

NewsLive TVMarketPopular CategoriesCalculatorsTrending NowLet's Connect with CNBCTV 18Network 18 Group :©TV18 Broadcast Limited. All rights reserved.